These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24973639)

  • 1. Interleukin-28A promotes IFN-γ production by peripheral blood mononuclear cells from patients with Behçet's disease.
    Li B; Xie C; Lin X; Su SB
    Cell Immunol; 2014 Jul; 290(1):116-9. PubMed ID: 24973639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of interleukin-27 and effect on production of interferon-γ and interleukin-17 in patients with Behçet's disease.
    Shen H; Xia LP; Lu J
    Scand J Rheumatol; 2013; 42(1):48-51. PubMed ID: 23101722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.
    Deniz R; Tulunay-Virlan A; Ture Ozdemir F; Unal AU; Ozen G; Alibaz-Oner F; Aydin-Tatli I; Mumcu G; Ergun T; Direskeneli H
    Immunol Invest; 2017 Jul; 46(5):518-525. PubMed ID: 28414558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of Th17 and related cytokines in Behçet's disease corresponding to disease activity.
    Na SY; Park MJ; Park S; Lee ES
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):32-40. PubMed ID: 24064012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
    Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease.
    Shimizu J; Takai K; Fujiwara N; Arimitsu N; Ueda Y; Wakisaka S; Yoshikawa H; Kaneko F; Suzuki T; Suzuki N
    Clin Exp Immunol; 2012 Apr; 168(1):68-74. PubMed ID: 22385240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to interphotoreceptor retinoid-binding protein and S-antigen in Behcet's patients with uveitis.
    Takeuchi M; Usui Y; Okunuki Y; Zhang L; Ma J; Yamakawa N; Hattori T; Kezuka T; Sakai J; Goto H
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3067-75. PubMed ID: 20089879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis.
    Chi W; Zhu X; Yang P; Liu X; Lin X; Zhou H; Huang X; Kijlstra A
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3058-64. PubMed ID: 18579762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.
    Lucherini OM; Lopalco G; Cantarini L; Emmi G; Lopalco A; Venerito V; Vitale A; Iannone F
    Immunol Lett; 2018 Sep; 201():38-44. PubMed ID: 30385329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behçet's disease.
    Aktas Cetin E; Cosan F; Cefle A; Deniz G
    Mod Rheumatol; 2014 Sep; 24(5):802-7. PubMed ID: 24498963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients.
    Sonmez C; Yucel AA; Yesil TH; Kucuk H; Sezgin B; Mercan R; Yucel AE; Demirel GY
    Clin Rheumatol; 2018 Oct; 37(10):2797-2804. PubMed ID: 29557072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Levels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Behçet's disease.
    Aridogan BC; Yildirim M; Baysal V; Inaloz HS; Baz K; Kaya S
    J Dermatol; 2003 Aug; 30(8):602-7. PubMed ID: 12928529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated IRAK1 and IRAK4 promoting the production of IFN-γ and IL-17 in Behcet's disease.
    Sun M; Yang P; Yang Y; Ye J
    Int Ophthalmol; 2018 Oct; 38(5):1947-1953. PubMed ID: 28780618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-17, IL-10, IL-6, and IFN-γ in Egyptian Behçet's disease: correlation with clinical manifestations.
    Talaat RM; Sibaii H; Bassyouni IH; El-Wakkad A
    Eur Cytokine Netw; 2019 Mar; 30(1):15-22. PubMed ID: 31122907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of interleukin-17 in Behcet's disease is inhibited by cyclosporin A.
    Chi W; Yang P; Zhu X; Wang Y; Chen L; Huang X; Liu X
    Mol Vis; 2010 May; 16():880-6. PubMed ID: 20508866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine profile in Behçet's disease patients. Relationship with disease activity.
    Hamzaoui K; Hamzaoui A; Guemira F; Bessioud M; Hamza M; Ayed K
    Scand J Rheumatol; 2002; 31(4):205-10. PubMed ID: 12369651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-alpha blocks IL-17 production by peripheral blood mononuclear cells in Behcet's disease.
    Liu X; Yang P; Wang C; Li F; Kijlstra A
    Rheumatology (Oxford); 2011 Feb; 50(2):293-8. PubMed ID: 21059671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A possible role for interleukin 37 in the pathogenesis of Behcet's disease.
    Ye Z; Wang C; Kijlstra A; Zhou X; Yang P
    Curr Mol Med; 2014 May; 14(4):535-42. PubMed ID: 24730521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-inflammatory cellular immune response in Behçet's disease.
    Kulaber A; Tugal-Tutkun I; Yentür SP; Akman-Demir G; Kaneko F; Gül A; Saruhan-Direskeneli G
    Rheumatol Int; 2007 Oct; 27(12):1113-8. PubMed ID: 17549482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-18 mRNA expression and IFN-gamma induction in bronchoalveolar lavage from Behçet's disease.
    Hamzaoui A; Ghraïri H; Ammar J; Zekri S; Guemira F; Hamzaoui K
    Clin Exp Rheumatol; 2003; 21(4 Suppl 30):S8-14. PubMed ID: 14727452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.